1	Serotypes	Serotype	B-NP	NNS	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	Vibrio	Vibrio	B-NP	NNP	O	4	NMOD
4	parahaemolyticus	parahaemolyticus	I-NP	NN	O	2	PMOD
5	from	from	B-PP	IN	O	4	NMOD
6	clinical	clinical	B-NP	JJ	O	9	NMOD
7	and	and	I-NP	CC	O	9	NMOD
8	environmental	environmental	I-NP	JJ	O	9	NMOD
9	sources	source	I-NP	NNS	O	5	PMOD
10	in	in	B-PP	IN	O	9	NMOD
11	Togo	Togo	B-NP	NNP	O	10	PMOD
12	(	(	O	(	O	15	DEP
13	West	West	B-NP	NNP	O	14	NMOD
14	Africa	Africa	I-NP	NNP	O	15	DEP
15	)	)	O	)	O	11	NMOD
16	.	.	O	.	O	1	P

1	Serological	Serological	B-NP	JJ	O	2	NMOD
2	analysis	analysis	I-NP	NN	O	8	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	O	O	B-NP	NN	O	7	NMOD
5	and	and	I-NP	CC	O	7	NMOD
6	K	K	I-NP	NN	B-protein	7	NMOD
7	antigens	antigen	I-NP	NNS	I-protein	3	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	performed	perform	I-VP	VBN	O	8	VC
10	on	on	B-PP	IN	O	9	VMOD
11	343	343	B-NP	CD	O	12	NMOD
12	strains	strain	I-NP	NNS	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	Vibro	Vibro	B-NP	NN	O	15	NMOD
15	parahaemolyticus	parahaemolyticus	I-NP	NN	O	13	PMOD
16	isolated	isolate	B-VP	VBN	O	15	NMOD
17	from	from	B-PP	IN	O	16	VMOD
18	clinical	clinical	B-NP	JJ	O	21	NMOD
19	and	and	I-NP	CC	O	21	NMOD
20	environmental	environmental	I-NP	JJ	O	21	NMOD
21	sources	source	I-NP	NNS	O	17	PMOD
22	in	in	B-PP	IN	O	21	NMOD
23	Togo	Togo	B-NP	NNP	O	22	PMOD
24	.	.	O	.	O	8	P

1	Only	Only	B-NP	RB	O	3	NMOD
2	two	two	I-NP	CD	O	3	NMOD
3	strains	strain	I-NP	NNS	O	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	not	not	O	RB	O	4	VMOD
6	typable	typable	B-ADJP	JJ	O	4	PRD
7	by	by	B-PP	IN	O	6	AMOD
8	the	the	B-NP	DT	O	11	NMOD
9	available	available	I-NP	JJ	O	11	NMOD
10	O	O	I-NP	NN	O	11	NMOD
11	antisera	antiserum	I-NP	NNS	O	7	PMOD
12	.	.	O	.	O	4	P

1	K	K	B-NP	NN	O	3	NMOD
2	untypable	untypable	I-NP	JJ	O	3	NMOD
3	strains	strain	I-NP	NNS	O	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	found	find	I-VP	VBN	O	4	VC
6	in	in	B-PP	IN	O	5	VMOD
7	4.8	4.8	B-NP	CD	O	8	NMOD
8	%	%	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	isolates	isolate	B-NP	NNS	O	9	PMOD
11	from	from	B-PP	IN	O	10	NMOD
12	gastroenteritis	gastroenteritis	B-NP	NN	O	13	NMOD
13	patients	patient	I-NP	NNS	O	11	PMOD
14	,	,	O	,	O	5	P
15	in	in	B-PP	IN	O	5	VMOD
16	11	11	B-NP	CD	O	17	NMOD
17	%	%	I-NP	NN	O	15	PMOD
18	from	from	B-PP	IN	O	17	NMOD
19	healthy	healthy	B-NP	JJ	O	20	NMOD
20	carriers	carrier	I-NP	NNS	O	18	PMOD
21	,	,	O	,	O	4	VMOD
22	and	and	O	CC	O	21	VMOD
23	in	in	B-PP	IN	O	22	PRD
24	47	47	B-NP	CD	O	25	NMOD
25	%	%	I-NP	NN	O	28	NMOD
26	and	and	O	CC	O	28	NMOD
27	46	46	B-NP	CD	O	28	NMOD
28	%	%	I-NP	NN	O	23	PMOD
29	of	of	B-PP	IN	O	28	NMOD
30	isolates	isolate	B-NP	NNS	O	29	PMOD
31	,	,	O	,	O	23	P
32	respectively	respectively	B-ADVP	RB	O	23	PMOD
33	,	,	O	,	O	23	PMOD
34	from	from	B-PP	IN	O	33	NMOD
35	water	water	B-NP	NN	O	38	NMOD
36	and	and	I-NP	CC	O	38	NMOD
37	fish	fish	I-NP	NN	O	38	NMOD
38	samples	sample	I-NP	NNS	O	34	PMOD
39	.	.	O	.	O	4	P

1	Thirteen	Thirteen	B-NP	CD	O	2	NMOD
2	serotypes	serotype	I-NP	NNS	O	6	SUB
3	identified	identify	B-VP	VBN	O	2	NMOD
4	in	in	B-PP	IN	O	3	VMOD
5	Togo	Togo	B-NP	NNP	O	4	PMOD
6	are	be	B-VP	VBP	O	0	ROOT
7	not	not	I-VP	RB	O	6	VMOD
8	considered	consider	I-VP	VBN	O	6	VC
9	in	in	B-PP	IN	O	8	VMOD
10	the	the	B-NP	DT	O	13	NMOD
11	Japanese	Japanese	I-NP	JJ	O	13	NMOD
12	antigenic	antigenic	I-NP	JJ	O	13	NMOD
13	scheme	scheme	I-NP	NN	O	9	PMOD
14	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	2	NMOD
2	suitability	suitability	I-NP	NN	O	14	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	the	the	B-NP	DT	O	7	NMOD
5	Japanese	Japanese	I-NP	JJ	O	7	NMOD
6	typing	typing	I-NP	NN	O	7	NMOD
7	scheme	scheme	I-NP	NN	O	3	PMOD
8	for	for	B-PP	IN	O	2	NMOD
9	geographic	geographic	B-NP	JJ	O	10	NMOD
10	areas	area	I-NP	NNS	O	8	PMOD
11	outside	outside	B-ADJP	JJ	O	10	NMOD
12	of	of	B-PP	IN	O	11	AMOD
13	Japan	Japan	B-NP	NNP	O	12	PMOD
14	is	be	B-VP	VBZ	O	19	VMOD
15	discussed	discuss	I-VP	VBN	O	14	VC
16	and	and	O	CC	O	19	VMOD
17	its	its	B-NP	PRP$	O	18	NMOD
18	extension	extension	I-NP	NN	O	19	SUB
19	is	be	B-VP	VBZ	O	0	ROOT
20	suggested	suggest	I-VP	VBN	O	19	VC
21	.	.	O	.	O	19	P

